Usher proteins in the inner ear structure and function
内耳结构和功能中引入蛋白质
基本信息
- 批准号:8458499
- 负责人:
- 金额:$ 38.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-01 至 2017-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesAuditoryBindingBinding ProteinsBiological ProcessBiologyBlindnessBuffersCalciumCalcium BindingCalcium-Binding ProteinsCell physiologyComplementComplexCoupledDataDevelopmentDiseaseEarEvoked PotentialsExonsFamilyFunctional disorderGene ProteinsGenesGeneticGoalsHair CellsHearingHearing Impaired PersonsHomeostasisHumanIn VitroIndividualInheritedIntegrin BindingKnock-in MouseKnockout MiceKnowledgeLabyrinthLifeLinkMYO7A geneMaintenanceMissionModelingMolecularMolecular ConformationMolecular GeneticsMorphologyMusMutant Strains MiceMutationOutcomeOuter Hair CellsPhysiologicalPreventionProcessPropertyProteinsResearchRodentRoleStereociliumStructureTechniquesTestingTherapeuticTherapeutic AgentsUnited StatesUsher SyndromeVisionWorkZebrafishbasedeafnessdisabilityhearing impairmentimprovedinnovationlateral linemouse modelmultidisciplinarymutantnovelpreventprotein functionpublic health relevanceskillssound
项目摘要
DESCRIPTION (provided by applicant): The molecular identities of many essential components of the hair cell stereocilia in the inner ear are still unknown, precluding our understanding of the precise mechanisms of the mechanotransduction (MET) of sound. To this end, studies of the gene/protein determinants of Usher Syndrome (USH), a neurosensory disorder affecting both hearing and vision in humans, have been fruitful in elucidating the molecular components of transduction machinery in the inner ear. The long-term goal of our research is to understand fully how USH proteins are involved in the biological processes of the inner ear as a means of developing new strategies to prevent and treat this dual neurosensory disorder. The objective of this particular application is to determine the role of a newly identifid USH protein, CIB2, in stereocilia bundle formation, Ca2+ homeostasis and MET, as well as the mechanisms underlying hearing impairment caused by the loss of CIB2 function. The CIB2 protein is encoded by CIB2, the causative gene for Usher syndrome type 1 and non-syndromic deafness in 58 human families. CIB2 is localized at the upper part of stereocilia of both inner and outer hair cells in the mouse inner ear. Based on strong preliminary data, the central hypothesis of this proposal is that CIB2 is a Ca2+-buffering protein required for the maintenance of Ca2+ homeostasis in the mechanosensory stereocilia of the inner ear hair cells. Loss of CIB2 function, then, will affect both the structure and mechanosensitivity of stereocilia bundles, resulting in hearing loss. The rationale for the proposed research is that once the function of CIB2 in the inner ear is known, this knowledge will improve our understanding of auditory MET and Ca2+ homeostasis processes at the molecular level, which will ultimately aid in developing therapeutic agents for preventing or reversing hearing loss. Thus, the proposed research is relevant to that part of NIH's mission that pertains to developing fundamental knowledge that will potentially help to reduce the burdens of human disability. This hypothesis will be tested by pursuing three specific aims: (1) elucidate the mechanism of hearing loss in Cib2F91S mice, (2) elucidate the role of CIB2 in the development and function of stereocilia bundles, and (3) elucidate potential interactions between CIB2 and known USH proteins present in the inner ear hair cell stereocilia. Our experimental approach is to define the consequences of loss of CIB2 on inner ear morphology, the MET current, adaptation, Ca2+ concentration in the stereocilia, cytoskeletal and ultra-structural alterations. Our studies will employ contemporary genetic, molecular, cellular, histochemical and physiological techniques. The approach is innovative, because CIB2 is a novel USH protein, therefore, its role in the hearing and vision processes has never been investigated. The proposed research is significant, first, because it is expected to provide mechanistic understanding of how CIB2 is involved in the structural development and function of inner ear hair cell stereocilia. Secondly, the proposed study will likely uncover the mechanisms and physiological significance of Ca2+ buffering in stereocilia, which is critically important in auditory MET.
描述(由申请人提供):内耳毛细胞静纤毛的许多基本成分的分子身份仍然是未知的,排除了我们对声音的机械转导(MET)的精确机制的理解。为此,对Usher综合征(USH)(一种影响人类听觉和视觉的神经感觉障碍)的基因/蛋白质决定簇的研究在阐明内耳转导机制的分子组成方面取得了丰硕成果。我们研究的长期目标是充分了解USH蛋白如何参与内耳的生物学过程,作为开发预防和治疗这种双重神经感觉障碍的新策略的手段。该特定应用的目的是确定新鉴定的USH蛋白CIB 2在静纤毛束形成、Ca 2+稳态和MET中的作用,以及CIB 2功能丧失引起的听力损伤的潜在机制。CIB 2蛋白由CIB 2编码,CIB 2是58个人类家族中Usher综合征1型和非综合征性耳聋的致病基因。CIB 2定位于小鼠内耳内、外毛细胞静纤毛的上部。基于强有力的初步数据,该建议的中心假设是CIB 2是维持内耳毛细胞的机械感觉静纤毛中的Ca 2+稳态所需的Ca 2+缓冲蛋白。CIB 2功能的丧失将影响静纤毛束的结构和机械敏感性,导致听力损失。这项研究的基本原理是,一旦CIB 2在内耳中的功能已知,这一知识将提高我们在分子水平上对听觉MET和Ca 2+稳态过程的理解,这将最终有助于开发预防或逆转听力损失的治疗药物。因此,拟议中的研究与NIH的使命的一部分有关,该使命涉及开发可能有助于减轻人类残疾负担的基础知识。该假设将通过追求三个具体目标来检验:(1)阐明Cib 2F 91 S小鼠中听力损失的机制,(2)阐明CIB 2在静纤毛束的发育和功能中的作用,以及(3)阐明CIB 2与存在于内耳毛细胞静纤毛中的已知USH蛋白之间的潜在相互作用。我们的实验方法是确定CIB 2损失对内耳形态,MET电流,适应,静纤毛中的Ca 2+浓度,细胞骨架和超微结构改变的后果。我们的研究将采用当代遗传、分子、细胞、组织化学和生理学技术。该方法是创新的,因为CIB 2是一种新的USH蛋白,因此,它在听觉和视觉过程中的作用从未被研究过。这项研究意义重大,首先是因为它有望为CIB 2如何参与内耳毛细胞静纤毛的结构发育和功能提供机制性理解。其次,该研究将可能揭示静纤毛中Ca 2+缓冲的机制和生理意义,这在听觉MET中至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zubair M. Ahmed其他文献
Genomic knockout of alms1 in zebrafish recapitulates Alström syndrome and provides insight into metabolic phenotypes
斑马鱼中 alms1 的基因组敲除再现了阿尔斯特罗姆综合征并提供了对代谢表型的深入了解
- DOI:
10.1101/439067 - 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Jessica E. Nesmith;Timothy L. Hostelley;C. C. Leitch;Maggie S. Matern;Saumil Sethna;R. McFarland;S. Lodh;Christopher J Westlake;R. Hertzano;Zubair M. Ahmed;N. Zaghloul - 通讯作者:
N. Zaghloul
CIB2 regulates autophagy via Rheb-mTORC1 signaling axis
CIB2 通过 Rheb-mTORC1 信号轴调节自噬
- DOI:
10.1101/2020.09.18.302265 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Saumil Sethna;S. Bernstein;X. Jian;S. Riazuddin;P. Randazzo;S. Riazuddin;Zubair M. Ahmed - 通讯作者:
Zubair M. Ahmed
Molecular mechanisms underlying CIB function in inner-ear mechanotransduction
- DOI:
10.1016/j.bpj.2021.11.327 - 发表时间:
2022-02-11 - 期刊:
- 影响因子:
- 作者:
Wei-Hsiang Weng;Jonathan Montgomery;Sanket Walujkar;Jeffrey M. Lotthammer;Arnaud P.J. Giese;Mark P. Foster;Zubair M. Ahmed;Marcos Sotomayor - 通讯作者:
Marcos Sotomayor
Potential therapy for progressive vision loss due to PCDH15-associated Usher Syndrome developed in an orthologous Usher mouse
在直系同源 Usher 小鼠中开发出针对 PCDH15 相关 Usher 综合征导致的渐进性视力丧失的潜在疗法
- DOI:
10.1101/2021.06.08.447565 - 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Saumil Sethna;W. Zein;Sehar Riaz;A. Giese;Julie M. Schultz;T. Duncan;R. Hufnagel;C. Brewer;A. Griffith;T Michael Redmond;S. Riazuddin;T. Friedman;Zubair M. Ahmed - 通讯作者:
Zubair M. Ahmed
Dual AAV-based emPCDH15/em gene therapy achieves sustained rescue of visual function in a mouse model of Usher syndrome 1F
基于双重腺相关病毒的 emPCDH15/em 基因疗法在 Usher 综合征 1F 小鼠模型中实现了视觉功能的持续挽救
- DOI:
10.1016/j.ymthe.2023.10.017 - 发表时间:
2023-12-06 - 期刊:
- 影响因子:12.000
- 作者:
Sehar Riaz;Saumil Sethna;Todd Duncan;Muhammad A. Naeem;T. Michael Redmond;Sheikh Riazuddin;Saima Riazuddin;Livia S. Carvalho;Zubair M. Ahmed - 通讯作者:
Zubair M. Ahmed
Zubair M. Ahmed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zubair M. Ahmed', 18)}}的其他基金
Molecular Determinants of Pigmentation (MDoP)
色素沉着的分子决定因素 (MDoP)
- 批准号:
10451535 - 财政年份:2021
- 资助金额:
$ 38.05万 - 项目类别:
Molecular Determinants of Pigmentation (MDoP)
色素沉着的分子决定因素 (MDoP)
- 批准号:
10665677 - 财政年份:2021
- 资助金额:
$ 38.05万 - 项目类别:
AMD-Patient-Derived hiPSC-RPE: Gateway for Assessing Novel and Emerging Modulators of Autophagy
AMD 患者衍生的 hiPSC-RPE:评估新型和新兴自噬调节剂的网关
- 批准号:
10283447 - 财政年份:2021
- 资助金额:
$ 38.05万 - 项目类别:
Molecular Determinants of Pigmentation (MDoP)
色素沉着的分子决定因素 (MDoP)
- 批准号:
10204448 - 财政年份:2021
- 资助金额:
$ 38.05万 - 项目类别:
AMD-Patient-Derived hiPSC-RPE: Gateway for Assessing Novel and Emerging Modulators of Autophagy
AMD 患者衍生的 hiPSC-RPE:评估新型和新兴自噬调节剂的网关
- 批准号:
10487506 - 财政年份:2021
- 资助金额:
$ 38.05万 - 项目类别:
Molecular Determinants of Usher Syndrome Disorder in Humans
人类亚瑟综合症的分子决定因素
- 批准号:
9899240 - 财政年份:2018
- 资助金额:
$ 38.05万 - 项目类别:
Molecular Determinants of Usher Syndrome Disorder in Humans
人类亚瑟综合症的分子决定因素
- 批准号:
10400017 - 财政年份:2018
- 资助金额:
$ 38.05万 - 项目类别:
Cell Type Specific Transcriptional Cascades in Inner Ear Development
内耳发育中细胞类型特异性转录级联
- 批准号:
10531224 - 财政年份:2015
- 资助金额:
$ 38.05万 - 项目类别:
Molecular Genetics of nonsyndromic Oculocutaneous Albinism
非综合征性眼皮肤白化病的分子遗传学
- 批准号:
8955726 - 财政年份:2014
- 资助金额:
$ 38.05万 - 项目类别:
Molecular Genetics of nonsyndromic Oculocutaneous Albinism
非综合征性眼皮肤白化病的分子遗传学
- 批准号:
8930443 - 财政年份:2014
- 资助金额:
$ 38.05万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 38.05万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 38.05万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 38.05万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 38.05万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 38.05万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 38.05万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 38.05万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 38.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 38.05万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 38.05万 - 项目类别: